Tamizaje para cáncer de pulmón: Tipos y evidencia

Abstract

The second cancer with the highest incidence and the leading cause of cancer death worldwide is lung cancer. This represents a public health issue in countries with populations at risk of developing this cancer. The main axis to reduce mortality from this cancer is the early detection of this pathology. To achieve this goal, imaging tests such as chest radiography and low dose computed tomography have been studied. The computer tomography is the one that has presented the greatest evidence in reducing mortality and with greater benefits than risks in the population at risk. Blood biomarkers are also being investigated as a method of screening against lung cancer. Despite the existence of evidence on screening methods, there are multiple adversities that can limit access to screening. These adversities are a major problem in the fight against this cancer and should not be underestimated.